Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HSDTNASDAQ:IVFNASDAQ:NDRANYSE:SONX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSDTHelius Medical Technologies$4.18-5.4%$4.85$3.32▼$24.00$1.71M1.1189,489 shs10,547 shsIVFINVO Fertility$1.68-5.6%$0.00$1.38▼$17.04$1.79M2.241.43 million shs159,587 shsNDRAENDRA Life Sciences$3.11-0.6%$4.16$2.90▼$577.50$2.30M0.19141,509 shs15,386 shsSONXSonendo$1.52$1.35$1.00▼$21.20$652K1.391,111 shs78 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSDTHelius Medical Technologies0.00%-2.22%-7.73%-48.20%-80.51%IVFINVO Fertility0.00%+167,999,900.00%+167,999,900.00%+167,999,900.00%+167,999,900.00%NDRAENDRA Life Sciences0.00%-3.72%-9.86%-28.18%-99.99%SONXSonendo0.00%0.00%+33.33%-47.95%+1,585.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHSDTHelius Medical Technologies0.7212 of 5 stars0.05.00.00.01.90.80.0IVFINVO FertilityN/AN/AN/AN/AN/AN/AN/AN/ANDRAENDRA Life Sciences1.738 of 5 stars3.52.00.00.01.30.01.3SONXSonendoN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSDTHelius Medical Technologies 2.00HoldN/AN/AIVFINVO Fertility 0.00N/AN/AN/ANDRAENDRA Life Sciences 3.00Buy$50.001,507.72% UpsideSONXSonendo 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SONX, IVF, HSDT, and NDRA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/21/2025NDRAENDRA Life SciencesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$75.00 ➝ $50.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSDTHelius Medical Technologies$434K3.94N/AN/A$3.32 per share1.26IVFINVO Fertility$6.53M0.27N/AN/AN/A∞NDRAENDRA Life SciencesN/AN/AN/AN/A$1,170.18 per shareN/ASONXSonendo$44.40M0.01N/AN/A$89.42 per share0.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSDTHelius Medical Technologies-$8.85M-$47.53N/A∞N/A-1,764.74%-244.82%-127.10%8/11/2025 (Estimated)IVFINVO FertilityN/A-$26.57N/A∞N/AN/AN/AN/AN/ANDRAENDRA Life Sciences-$10.06M-$172.04N/AN/AN/AN/A-127.39%-103.77%8/13/2025 (Estimated)SONXSonendo-$60.92M-$59.12N/A∞N/A-92.74%-184.01%-68.60%6/10/2025 (Estimated)Latest SONX, IVF, HSDT, and NDRA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025IVFINVO FertilityN/A-$12.53N/A-$12.53N/A$1.64 million5/1/2025Q1 2025HSDTHelius Medical Technologies-$0.58-$0.51+$0.07-$0.51N/A$0.05 million3/31/2025Q4 2024NDRAENDRA Life Sciences-$4.10-$9.40-$5.30-$20.78N/AN/A3/25/2025Q4 2024HSDTHelius Medical Technologies-$14.10-$15.45-$1.35-$1.03$0.10 million$0.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHSDTHelius Medical TechnologiesN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/ANDRAENDRA Life SciencesN/AN/AN/AN/AN/ASONXSonendoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSDTHelius Medical TechnologiesN/A3.613.10IVFINVO FertilityN/AN/AN/ANDRAENDRA Life SciencesN/A6.106.10SONXSonendo0.551.821.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSDTHelius Medical Technologies18.63%IVFINVO Fertility12.02%NDRAENDRA Life Sciences1.19%SONXSonendo28.68%Insider OwnershipCompanyInsider OwnershipHSDTHelius Medical Technologies17.90%IVFINVO Fertility1.79%NDRAENDRA Life Sciences0.04%SONXSonendo7.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSDTHelius Medical Technologies30409,0003.54 millionNot OptionableIVFINVO Fertility101.07 millionN/AN/ANDRAENDRA Life Sciences20738,000537,000Not OptionableSONXSonendo250429,000393,000Not OptionableSONX, IVF, HSDT, and NDRA HeadlinesRecent News About These CompaniesSonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 26, 2025 | businesswire.comSonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024November 11, 2024 | businesswire.comSonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseNovember 5, 2024 | zacks.comSonendo Launches ProControlTM for the GentleWave® G4 SystemOctober 23, 2024 | businesswire.comSonendo, Inc. Announces Preliminary Third Quarter 2024 Financial ResultsOctober 10, 2024 | businesswire.comBIOLASE files for Chapter 11, plans asset sale to SonendoOctober 3, 2024 | investing.comHere's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock NowAugust 27, 2024 | zacks.comSonendo Inc.August 17, 2024 | marketwatch.comSonendo, Inc. (SONX) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comSonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue EstimatesAugust 7, 2024 | zacks.comSonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue GuidanceAugust 7, 2024 | finance.yahoo.comHere's what Wall Street expects from Sonendo's earnings reportAugust 7, 2024 | markets.businessinsider.comSonendo, Inc. (SONX)July 28, 2024 | finance.yahoo.comSonendo Strengthens Leadership With Key Strategic AppointmentsJune 5, 2024 | businesswire.comSonendo to Present at the 2024 Stifel Jaws & Paws ConferenceMay 20, 2024 | businesswire.comSonendo, Inc. (SONX) Q1 2024 Earnings Call TranscriptMay 12, 2024 | seekingalpha.comSonendo, Inc. (NYSE:SONX) Q1 2024 Earnings Call TranscriptMay 12, 2024 | msn.comSonendo Inc (SONX) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and Financial ...May 9, 2024 | finance.yahoo.comSONX Stock Earnings: Sonendo Misses EPS, Beats Revenue for Q1 2024May 8, 2024 | investorplace.comSonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset PrioritiesMay 8, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongBy Sam Quirke | May 13, 2025View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumNVIDIA Stock Surges on Bullish News: How High Could It Climb?By Thomas Hughes | May 13, 2025View NVIDIA Stock Surges on Bullish News: How High Could It Climb?IBM's AI Offensive: Assessing IBM's Path to Renewed GrowthBy Jeffrey Neal Johnson | May 8, 2025View IBM's AI Offensive: Assessing IBM's Path to Renewed GrowthSONX, IVF, HSDT, and NDRA Company DescriptionsHelius Medical Technologies NASDAQ:HSDT$4.18 -0.24 (-5.43%) Closing price 05/23/2025 03:46 PM EasternExtended Trading$4.01 -0.17 (-4.07%) As of 05/23/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.INVO Fertility NASDAQ:IVF$1.68 -0.10 (-5.62%) As of 05/23/2025 04:00 PM EasternNAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).ENDRA Life Sciences NASDAQ:NDRA$3.11 -0.02 (-0.64%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$3.11 0.00 (0.00%) As of 05/23/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.Sonendo NYSE:SONX$1.52 0.00 (0.00%) As of 05/23/2025Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
